DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment

Clinical trial NCT07158164 · RECRUITING

Trial details

NCT number: NCT07158164
Sponsor: Rutgers, The State University of New Jersey
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Colorectal Neoplasms Breast Neoplasms Head and Neck Neoplasms Gastro-Intestinal Intraepithelial Neoplasia

Start date: 2025-08-27
Primary completion: 2027-07-07
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.